Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mark Lambton"'
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Understanding the economic value of deucravacitinib and apremilast could assist treatment decision-making for patients with moderate to severe plaque psoriasis.Objective This study compared the cost per response (CPR) for US patients initi
Externí odkaz:
https://doaj.org/article/f02293324a8649d49be744bac27d627a
Autor:
Alison Davie, Sory Traoré, Massimo Giovannitti, Giuseppe Pompilio, Mark Lambton, Esra Cakar, Anuja Chatterjee
Publikováno v:
Global & Regional Health Technology Assessment, Vol 10, Iss 1 (2023)
Background: Abemaciclib was recently approved by the European Medicines Agency in combination with adjuvant endocrine therapy (ET) for adult patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2−), n
Externí odkaz:
https://doaj.org/article/9ce25b8009594acfa444f2b72eb4cbed